Literature DB >> 28768787

Factors affecting the rate of surgical site infection in patients after hemiarthroplasty of the hip following a fracture of the neck of the femur.

L de Jong1, T M A L Klem2, T M Kuijper1, G R Roukema1.   

Abstract

AIMS: Surgical site infection can be a devastating complication of hemiarthroplasty of the hip, when performed in elderly patients with a displaced fracture of the femoral neck. It results in a prolonged stay in hospital, a poor outcome and increased costs. Many studies have identified risk and prognostic factors for deep infection. However, most have combined the rates of infection following total hip arthroplasty and internal fixation as well as hemiarthroplasty, despite the fact that they are different entities. The aim of this study was to clarify the risk and prognostic factors causing deep infection after hemiarthroplasty alone. PATIENTS AND METHODS: Data were extracted from a prospective hip fracture database and completed by retrospective review of the hospital records. A total of 916 patients undergoing a hemiarthroplasty in two level II trauma teaching hospitals between 01 January 2011 and 01 May 2016 were included. We analysed the potential peri-operative risk factors with univariable and multivariable logistic regression analysis.
RESULTS: A total of 92 patients (10%) had a surgical site infection, and 44 (4.9%) developed a deep infection. After univariable analyses, the multivariable model showed that the level of experience of the surgeon measured by the number of hemiarthroplasties performed per year was a significant prognostic factor (odds ratio (OR) 0.93, p = 0.042) for the development of an infection. Secondly, the development of a haematoma (OR 9.6, p < 0.001), a re-operation (OR 4.7, p = 0.004) and an operating time of < 45 mins (OR 5.1, p = 0.002) or > 90 mins (OR 2.7, p = 0.034) were also significant factors.
CONCLUSION: There was a significant association between the experience of the surgeon and the rate of deep infection. Secondly, a haematoma, a re-operation and both shorter and longer operating times were associated with an increased risk of deep infection after hemiarthroplasty. No association was found between deep infection and the anatomical approach, the time when surgery was undertaken and the use of a drain. Cite this article: Bone Joint J 2017;99-B:1088-94. ©2017 The British Editorial Society of Bone & Joint Surgery.

Entities:  

Keywords:  Femoral neck fracture; Hemiarthroplasty; Hip fracture; Risk and prognostic factors; Surgical site infection

Mesh:

Year:  2017        PMID: 28768787     DOI: 10.1302/0301-620X.99B8.BJJ-2016-1119.R1

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  27 in total

1.  The minimally invasive anterolateral approach versus the traditional anterolateral approach (Watson-Jones) for hip hemiarthroplasty after a femoral neck fracture: an analysis of clinical outcomes.

Authors:  Louis de Jong; Taco M A L Klem; Tjallingius M Kuijper; Gert R Roukema
Journal:  Int Orthop       Date:  2018-01-06       Impact factor: 3.075

2.  Periprosthetic joint infection in aseptic total hip arthroplasty revision.

Authors:  Guillaume Renard; Jean-Michel Laffosse; Meagan Tibbo; Thibault Lucena; Etienne Cavaignac; Jean-Louis Rouvillain; Philippe Chiron; Mathieu Severyns; Nicolas Reina
Journal:  Int Orthop       Date:  2019-06-25       Impact factor: 3.075

3.  Antibiotic prophylaxis as a quality of care indicator: does it help in the fight against surgical site infections following fragility hip fractures?

Authors:  Tal Frenkel Rutenberg; Anat Aizer; Avraham Levi; Noa Naftali; Shelly Zeituni; Steven Velkes; Anat Aka Zohar
Journal:  Arch Orthop Trauma Surg       Date:  2020-11-20       Impact factor: 3.067

4.  Cemented versus uncemented hemiarthroplasty for displaced femoral neck fractures: A randomized controlled trial with two years follow-up.

Authors:  Igor Movrin
Journal:  Acta Orthop Traumatol Turc       Date:  2020-01       Impact factor: 1.511

5.  Incidence and risk factors of surgical site infection after intertrochanteric fracture surgery: A prospective cohort study.

Authors:  Kuo Zhao; Junzhe Zhang; Junyong Li; Hongyu Meng; Zhongzheng Wang; Yanbin Zhu; Zhiyong Hou; Yingze Zhang
Journal:  Int Wound J       Date:  2020-08-24       Impact factor: 3.315

6.  Cementless Stem for Femoral Neck Fractures in a Patient's 10th Decade of Life: High Rate of Periprosthetic Fractures.

Authors:  Method Kabelitz; Yannick Fritz; Patrick Grueninger; Christoph Meier; Patrick Fries; Michael Dietrich
Journal:  Geriatr Orthop Surg Rehabil       Date:  2018-03-29

7.  Target site antibiotic concentrations in orthopedic/trauma extremity surgery: is prophylactic cefazolin adequately dosed? A systematic review and meta-analysis.

Authors:  Fay R K Sanders; J Carel Goslings; Ron A A Mathôt; Tim Schepers
Journal:  Acta Orthop       Date:  2019-02-11       Impact factor: 3.717

8.  Delirium after hip hemiarthroplasty for proximal femoral fractures in elderly patients: risk factors and clinical outcomes.

Authors:  Louis de Jong; Veronique A J I M van Rijckevorsel; Jelle W Raats; Taco M A L Klem; Tjallingius M Kuijper; Gert R Roukema
Journal:  Clin Interv Aging       Date:  2019-02-26       Impact factor: 4.458

9.  The factors associated with nosocomial infection in elderly hip fracture patients: gender, age, and comorbidity.

Authors:  Yuan Deng; Zhong Zheng; Shi Cheng; Yuan Lin; Duanyang Wang; Pengbin Yin; Zhi Mao; Peifu Tang
Journal:  Int Orthop       Date:  2021-08-05       Impact factor: 3.075

10.  Risk factors for the development of aspiration pneumonia in elderly patients with femoral neck and trochanteric fractures: A retrospective study of a patient cohort.

Authors:  Toshihiro Higashikawa; Kenji Shigemoto; Kenichi Goshima; Daisuke Usuda; Masashi Okuro; Manabu Moriyama; Hiromi Inujima; Masahiro Hangyou; Kimiko Usuda; Shigeto Morimoto; Tadami Matsumoto; Shigeki Takashima; Tsugiyasu Kanda; Takeshi Sawaguchi
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.